Biotalk, Episode 5, Fred Chereau, LogicBio

In this episode of Biotalk, Josh Hamermesh, VP of Locust Walk, spoke to Fred Chereau, CEO of LogicBio, an innovative early-stage gene therapy company that recently completed a $50M financing. During the conversation, Josh and Fred discussed career paths, industry trends, gene therapy and the keys to LogicBio’s successful financing.

To hear the full conversation, listen below:

<iframe width="500" height="500" scrolling="no" frameborder="no" src=""></iframe>

Subscribe here:


Click on the icons below to share on:


<script src="//" type="text/javascript"> lang: en_US</script> <script type="IN/Share" data-url="></script>